Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
The Latest on: Pain medications
via Google News
The Latest on: Pain medications
- INSLA commends Ghanaian Surgeon for manufacturing NCDs medicationon January 24, 2021 at 5:46 pm
The Institute of Leadership and Development (INSLA), a non-profit civil society centre, has commended Dr Michael K. Obeng, a surgeon, for establishing a pharmaceutical plant in Ghana to manufacture ...
- What Factors Play a Role in Whether Someone Becomes Addicted to Prescription Drugs?on January 24, 2021 at 4:46 pm
Prescription drug addiction is a growing epidemic. Find out if you have the risk factors to become addicted to prescription drugs.
- Opioid Withdrawal Medications: Why Medical Supervision Is Importanton January 24, 2021 at 4:44 pm
Opioid withdrawal medications may help control your symptoms, but just like many forms of medicine, medical supervision is crucial.
- Global Bone Pain Treatment Market Recent Trends, Growth Opportunities, Forecast By Application And Types To 2023on January 23, 2021 at 12:12 am
Jan (Heraldkeepers) -- Market Research Future has starting late imparted another examination to its wide research portfolio, which is titled ...
- Plattsburgh police warn of counterfeit medication sold in areaon January 22, 2021 at 8:46 pm
The Plattsburgh City Police Department is investigating suspected counterfeit pain medications being presented as oxycodone in illegal drug sales. According to a news release from the North Country ...
- Study: Pain Regimen Treats Surgical Trauma Patients with Fewer Opioidson January 22, 2021 at 9:14 am
Opioids should not be considered the pillar of treatment for acute pain after injury,” said lead study author John A. Harvin, MD, FACS, associate professor for the department of surgery, McGovern ...
- Over-the-Counter Pain Medication Market will Exhibit a Steady 4.0% CAGR through 2028on January 22, 2021 at 3:38 am
The OTC (over-the-counter) pain medication market surpassed US$ 18 billion in 2018, with growth influenced by changing perceptions on generic ...
- Pain-relief regimen treats trauma patients with fewer opioid drugson January 21, 2021 at 8:18 am
A multimodal pain regimen (MMPR) designed to minimize opioid exposure and relieve acute pain associated with traumatic injury kept patient self-reported pain scores low while also reducing the daily ...
- Study shows antidepressant drugs are largely ineffective for back and osteoarthritis painon January 20, 2021 at 8:39 pm
Antidepressant drugs are largely ineffective for back and osteoarthritis pain, despite being widely used for these conditions, suggests a review of the evidence published by The BMJ today.
via Bing News